Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Oct 18, 2025

High-throughput Titration of Luciferase-expressing Recombinant Viruses
08:09

High-throughput Titration of Luciferase-expressing Recombinant Viruses

Published on: September 19, 2014

13.1K

Personalized Virus Load Curves for Acute Viral Infections.

Carlos Contreras1,2, Jay M Newby1,2, Thomas Hillen1,2

  • 1Department of Mathematical and Statistical Sciences, University of Alberta, Edmonton, AB T6G 2R3, Canada.

Viruses
|September 28, 2021
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

50 Years Journal of Mathematical Biology.

Journal of mathematical biology·2025
Same author

How the tulip breaking virus creates striped tulips.

Communications biology·2025
Same author

Modelling microtube driven invasion of glioma.

Journal of mathematical biology·2023
Same author

Cooperative motility, force generation and mechanosensing in a foraging non-photosynthetic diatom.

Open biology·2023
Same author

The Tumor Invasion Paradox in Cancer Stem Cell-Driven Solid Tumors.

Bulletin of mathematical biology·2022
Same author

HSP70 chaperones RNA-free TDP-43 into anisotropic intranuclear liquid spherical shells.

Science (New York, N.Y.)·2020
Same journal

Correction: Bulatov et al. Camelpox Virus in Western Kazakhstan: Assessment of the Role of Local Fauna as Reservoirs of Infection. <i>Viruses</i> 2024, <i>16</i>, 1626.

Viruses·2026
Same journal

Correction: Franco et al. Whole Blood Volume-Based Absolute Quantification of HTLV-1 Proviral Load: A Comparative Method Evaluation Study. <i>Viruses</i> 2026, <i>18</i>, 580.

Viruses·2026
Same journal

Correction: Medkour et al. Adenovirus Infections in African Humans and Wild Non-Human Primates: Great Diversity and Cross-Species Transmission. <i>Viruses</i> 2020, <i>12</i>, 657.

Viruses·2026
Same journal

Burden of Malaria and Dengue Across Global, Asian, and Chinese Populations Based on GBD 2021 Data: A Quantitative Assessment of Importation Risks to China.

Viruses·2026
Same journal

First Report of <i>Orthonairovirus songlingense</i> in <i>Haemaphysalis concinna</i> Ticks from Russia.

Viruses·2026
Same journal

Epidemiological and Virological Characteristics of H9N2 Avian Influenza Virus in Jiangsu Province, China, 2024.

Viruses·2026
See all related articles

We developed a new explicit function for patient-specific virus load curves in acute viral infections. This model simplifies analysis and accurately fits influenza and SARS-CoV-2 data, showing individual disease variability.

Area of Science:

  • Virology
  • Mathematical Biology
  • Infectious Disease Modeling

Background:

  • Accurate modeling of virus load dynamics is crucial for understanding acute viral infections.
  • Existing models often require complex computations, limiting patient-specific analysis.
  • Individual variability in disease progression necessitates adaptable modeling approaches.

Purpose of the Study:

  • To introduce a novel, explicit function for describing patient-specific virus load curves.
  • To enable simplified analysis of acute viral infections without complex dynamic models.
  • To provide a new tool for estimating infection growth rates and assessing patient risk.

Main Methods:

  • Developed an explicit function based on intuitive model parameters for virus load.
Keywords:
SARS-CoV-2mathematical modelingpatient specificviral load

More Related Videos

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

30.5K
Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses
11:19

Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses

Published on: May 4, 2015

11.3K

Related Experiment Videos

Last Updated: Oct 18, 2025

High-throughput Titration of Luciferase-expressing Recombinant Viruses
08:09

High-throughput Titration of Luciferase-expressing Recombinant Viruses

Published on: September 19, 2014

13.1K
Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds
09:29

Early Viral Entry Assays for the Identification and Evaluation of Antiviral Compounds

Published on: October 29, 2015

30.5K
Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses
11:19

Pairwise Growth Competition Assay for Determining the Replication Fitness of Human Immunodeficiency Viruses

Published on: May 4, 2015

11.3K
  • Validated the function using diverse datasets: influenza A (mice and human), human rhinovirus, and SARS-CoV-2 (monkey and human).
  • Compared the explicit function against an established target model and exponential approximations.
  • Main Results:

    • The explicit function accurately describes patient-specific virus load curves across multiple viral infections.
    • Wide parameter distributions indicate significant inter-individual variability in disease outcomes.
    • The function, target model, and approximations demonstrated excellent data fits.

    Conclusions:

    • The new virus load function provides an effective method for analyzing patient-specific viral data.
    • It can be integrated into higher-level models for physiological effects, tissue damage, and risk assessment.
    • This approach simplifies virus load analysis and accounts for individual patient differences.